Skip to main content
Siyang Leng, MD, Oncology, New York, NY

SiyangLengMD

Oncology New York, NY

Hematologic Oncology

Physician

Dr. Leng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Leng's full profile

Already have an account?

  • Office

    161 Fort Washington Avenue
    0
    New York, NY 10032

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2013 - 2016
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 2009 - 2012
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2009

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2013 - 2026
  • PA State Medical License
    PA State Medical License 2012 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Combination Chemotherapy with Carfilzomib, Bendamustine and Dexamethasone Is Highly Active for Therapy of Newly Diagnosed Multiple Myeloma-Results of Single Center Pha...
    Siyang Leng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Factors associated with over and underuse of response evaluation in elderly myeloma patients. 
    ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
  • A phase 1/2 study of carfilzomib, bendamustine, and dexamethasone (CBD) in newly diagnosed multiple myeloma patients. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018